Stock Research: Medicover

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Medicover

STO:MCOV B SE0009778848
63
  • Value
    43
  • Growth
    96
  • Safety
    Safety
    6
  • Combined
    52
  • Sentiment
    72
  • 360° View
    360° View
    63
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers healthcare services (primary care, specialist outpatient and inpatient care via clinics and medical facilities) and diagnostic services (laboratory testing for humans and some veterinary services). The company primarily operates in Poland, Germany, Romania, and Ukraine. In the last fiscal year, the company had a market cap of $4085 million, profits of $464 million, revenue of $2166 million, and 47256 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
43 34 28 29
Growth
96 98 100 87
Safety
Safety
6 9 14 42
Sentiment
72 42 42 41
360° View
360° View
63 39 41 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
34 51 41 43
Opinions Change
75 50 83 50
Pro Holdings
n/a 24 4 30
Market Pulse
58 49 59 56
Sentiment
72 42 42 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
43 34 28 29
Growth
96 98 100 87
Safety Safety
6 9 14 42
Combined
52 34 41 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
80 75 73 64
Price vs. Earnings (P/E)
18 17 10 13
Price vs. Book (P/B)
16 16 22 18
Dividend Yield
54 45 47 48
Value
43 34 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
87 85 94 84
Profit Growth
100 88 71 96
Capital Growth
81 68 93 6
Stock Returns
49 90 57 97
Growth
96 98 100 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
5 5 16 46
Refinancing
14 16 15 37
Liquidity
31 24 24 30
Safety Safety
6 9 14 42

Similar Stocks

Discover high‑ranked alternatives to Medicover and broaden your portfolio horizons.

STMicroelectronics

PAR:STMPA
Country: Netherlands
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

KSB

GER:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Magyar Telekom

BUD:MTELEKOM
Country: Hungary
Industry: Integrated Telecommunication
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: